Corticosteroids are an efficient treatment for active Crohn's disease.
The treatment has to be undertaken with a daily intake equivalent to
1 mg/kg per day of prednisolone for a 3 to 7 weeks period. Immunosuppr
essive agents are indicated in case of corticodependency or in case of
large intestinal resection. Artificial nutrition (enteral or parenter
al) is proposed in corticoresistant forms, and is usually followed by
an immunosuppressive therapy. Surgical management is reserved for comp
lications, including resistance to all medical therapy. Surgical resec
tion has to be limited in order to avoid a short bowel syndrom. Surger
y should not be considered as the ideal therapy as it has been demonst
rated that recurrence after surgery increases at distance. 5-aminosaly
cilates compounds are an alternative therapy in mild attacks. Mesalazi
ne may reduce the recurrence and could be considered as a possible mai
ntenance treatment.